Table 2.
Comparison of risk factors between patients with and without AKI
| Characteristic | AKI (n = 25) | Non-AKI (n = 27) | p value |
|---|---|---|---|
| Sepsis | 4 (16%) | 0 (0%) | 0.047 |
| Shock | 10 (40%) | 2 (7.4%) | 0.005 |
| Anemia | 21 (84%) | 16 (59.3%) | 0.049 |
| Antepartum hemorrhage | 2 (8%) | 1 (3.7%) | 0.603 |
| Postpartum hemorrhage (>500 mL) | 12 (48%) | 10 (37%) | 0.424 |
| Postpartum hemorrhage (>1000 mL) | 1 (4%) | 1 (3.7%) | 1.000 |
| Preexisting comorbidities | 7 (28%) | 5 (18.5%) | 0.417 |
| HELLP syndrome | 8 (32%) | 4 (14.8%) | 0.142 |
| Previous surgery (including previous cesarean) | 3 (12.5%) | 7 (25.9%) | 0.254 |
| DIC | 0 (0%) | 0 (0%) | — |
| Trauma | 0 (0%) | 0 (0%) | — |
| Acute fatty liver | 0 (0%) | 0 (0%) | — |
| Radiocontrast agents | 0 (0%) | 0 (0%) | — |
| Diabetes mellitus | 0 (0%) | 0 (0%) | — |
| Nephrotoxic drugs | 0 (0%) | 0 (0%) | — |
| Eclampsia | 18 (72%) | 21 (77.8%) | 0.631 |
| Pulmonary edema | 4 (16%) | 3 (11.1%) | 0.698 |
| Urinary protein* | 2 (1–2) | 1 (1–2) | 0.096 |
Values are number of patients (% of patients within respective group) or median (IQR); HELLP, hemolysis, elevated liver enzyme, and low platelet count; DIC, disseminated intravascular coagulopathy;
*
proteinuria measured by urinary dipstick method